ASCO in ActionASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.

To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.

Tune in to ASCO's new ASCO in Action podcast series, providing analysis and commentary on cancer policy and practice issues, available through iTunes or Google Play.

Showing results for Congress

February 19, 2019

Urge Congress to support the CLINICAL TREATMENT Act, which would guarantee coverage of the routine care costs of clinical trial participation for Medicaid enrollees with a life-threatening condition.

February 15, 2019

President Trump signed into law a funding bill that provides FDA with $3.08 billion in government funding for fiscal year 2019 – a $269 million increase, and the largest boost to FDA in at least five years.

January 22, 2019

As the 116th Session of the U.S. Congress gets underway in Washington, D.C., committees and subcommittees with jurisdiction over cancer-related policy priorities are taking shape and selecting new and returning leadership. With this committee leadership in place, ASCO will continue its efforts to advance policy priorities including: federal funding for cancer research, patient access to clinical trials, oral parity legislation, and other potential barriers to care such as the high cost of cancer drug treatment, step therapy, and prior authorization policies.

January 18, 2019

The American Society of Clinical Oncology (ASCO), along with nearly 60 other organizations, joined the American Cancer Society Cancer Action Network (ACS CAN) in an advertising campaign urging the Department of Health and Human Services (HHS) and Congress to halt proposed changes to Medicare Part D’s six protected classes.